Tumor-infiltrating CD8+ T cell antitumor efficacy and exhaustion: molecular insights

被引：39
|
作者：
Kumar, Sandeep [1 ]
Singh, Sunil Kumar [1 ]
Rana, Basabi [1 ,2 ,3 ]
Rana, Ajay [1 ,2 ,3 ]
机构：
[1] Univ Illinois, Div Surg Oncol, Dept Surg, Chicago, IL 60612 USA
[2] Univ Illinois, Univ Illinois Hosp & Hlth Sci Syst Canc Ctr, Chicago, IL 60612 USA
[3] Jesse Brown VA Med Ctr, Chicago, IL 60612 USA
来源：
DRUG DISCOVERY TODAY | 2021年 / 26卷 / 04期
关键词：
INTRATUMORAL IMMUNOTHERAPY; LYMPHOCYTE THERAPY; PHOSPHORYLATED ERK; PD-1; BLOCKADE; LUNG-CANCER; CHECKPOINT; MELANOMA; IMMUNITY; ANTIGEN; AGONIST;
D O I：
10.1016/j.drudis.2021.01.002
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Host immunity has an essential role in the clinical management of cancers. Therefore, it is advantageous to choose therapies that can promote tumor cell death and concurrently boost host immunity. The dynamic tumor microenvironment (TME) determines whether an antineoplastic drug will elicit favorable or disparaging immune responses from tumor-infiltrating lymphocytes (TILs). CD8+ T cells are one of the primary tumor-infiltrating immune cells that deliver antitumor responses. Here, we review the influence of various factors in the TME on CD8+ T cell exhaustion and survival, and possible strategies for restoring CD8+ T cell effector function through immunotherapy.
引用
收藏
页码：951 / 967
页数：17
相关论文
共 50 条
  • [41] HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+ T lymphocytes
    Gooden, Marloes
    Lampen, Margit
    Jordanova, Ekaterina S.
    Leffers, Ninke
    Trimbos, J. Baptist
    van der Burg, Sjoerd H.
    Nijman, Hans
    van Hall, Thorbald
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (26) : 10656 - 10661
  • [42] Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer
    Mahmoud, Sahar M. A.
    Paish, Emma Claire
    Powe, Desmond G.
    Macmillan, R. Douglas
    Grainge, Matthew J.
    Lee, Andrew H. S.
    Ellis, Ian O.
    Green, Andrew R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) : 1949 - 1955
  • [43] Correction to: Transcriptome of CD8+ tumor-infiltrating T cells: a link between diabetes and colorectal cancer
    Reem Saleh
    Varun Sasidharan Nair
    Khaled Murshed
    Mohamed Abu Nada
    Eyad Elkord
    Ranad Shaheen
    Cancer Immunology, Immunotherapy, 2021, 70 : 2639 - 2640
  • [44] Fundamentals to therapeutics: Epigenetic modulation of CD8+ T Cell exhaustion in the tumor microenvironment
    Blake, Maja K.
    O'Connell, Patrick
    Aldhamen, Yasser A.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 10
  • [45] Defective adhesion in tumor infiltrating CD8+ T cells
    Koneru, Mythili
    Monu, Ngozi
    Schaer, David
    Barletta, Justine
    Frey, Alan B.
    JOURNAL OF IMMUNOLOGY, 2006, 176 (10): : 6103 - 6111
  • [46] Tumor-infiltrating CD5+ regulatory B1 cells suppress melanoma tumor immunity via inhibiting cytokine production of tumor-infiltrating CD8+ T cells
    Kobayashi, T.
    Matsushita, T.
    Hamaguchi, Y.
    Fujimoto, M.
    Takehara, K.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S1 - S1
  • [47] Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8+ Tumor-Infiltrating T Lymphocyte Responses
    Abd Hamid, Megat
    Wang, Ruo-Zheng
    Yao, Xuan
    Fan, Peiwen
    Li, Xi
    Chang, Xue-Mei
    Feng, Yaning
    Jones, Stephanie
    Maldonado-Perez, David
    Waugh, Craig
    Verrill, Clare
    Simmons, Alison
    Cerundolo, Vincenzo
    McMichael, Andrew
    Conlon, Christopher
    Wang, Xiyan
    Peng, Yanchun
    Dong, Tao
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (08) : 1293 - 1306
  • [48] CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes
    Parodi, Alessia
    Battaglia, Florinda
    Kalli, Francesca
    Ferrera, Francesca
    Conteduca, Giuseppina
    Tardito, Samuele
    Stringara, Silvia
    Ivaldi, Federico
    Negrini, Simone
    Borgonovo, Giacomo
    Simonato, Alchiede
    Traverso, Paolo
    Carmignani, Giorgio
    Fenoglio, Daniela
    Filaci, Gilberto
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (05) : 851 - 862
  • [49] CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes
    Alessia Parodi
    Florinda Battaglia
    Francesca Kalli
    Francesca Ferrera
    Giuseppina Conteduca
    Samuele Tardito
    Silvia Stringara
    Federico Ivaldi
    Simone Negrini
    Giacomo Borgonovo
    Alchiede Simonato
    Paolo Traverso
    Giorgio Carmignani
    Daniela Fenoglio
    Gilberto Filaci
    Cancer Immunology, Immunotherapy, 2013, 62 : 851 - 862
  • [50] Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8+ T-myeloid cell networks in melanoma
    Barras, David
    Ghisoni, Eleonora
    Chiffelle, Johanna
    Orcurto, Angela
    Dagher, Julien
    Fahr, Noemie
    Benedetti, Fabrizio
    Crespo, Isaac
    Grimm, Alizee J.
    Morotti, Matteo
    Zimmermann, Stefan
    Duran, Rafael
    Imbimbo, Martina
    de Olza, Maria Ochoa
    Navarro, Blanca
    Homicsko, Krisztian
    Bobisse, Sara
    Labes, Danny
    Tsourti, Zoe
    Andriakopoulou, Charitini
    Herrera, Fernanda
    Petremand, Remy
    Dummer, Reinhard
    Berthod, Gregoire
    Kraemer, Anne I.
    Huber, Florian
    Thevenet, Jonathan
    Bassani-Sternberg, Michal
    Schaefer, Niklaus
    Prior, John O.
    Matter, Maurice
    Aedo, Veronica
    Dromain, Clarisse
    Corria-Osorio, Jesus
    Tissot, Stephanie
    Kandalaft, Lana E.
    Gottardo, Raphael
    Pittet, Mikael
    Sempoux, Christine
    Michielin, Olivier
    Dafni, Urania
    Trueb, Lionel
    Harari, Alexandre
    Laniti, Denarda Dangaj
    Coukos, George
    SCIENCE IMMUNOLOGY, 2024, 9 (92)
12345